The Singulex Clinical Laboratory currently offers more than 60 blood tests that primarily focus on the assessment of chronic conditions such as cardiovascular health, inflammation, diabetes, abnormal cholesterol, or hormone imbalances, as well as cancer monitoring.

Singulex offers five blood tests that apply its proprietary technology to measure cardiovascular health and inflammation. These five tests are ONLY offered through the Singulex Clinical Laboratory.

Singulex uses a proprietary Single Molecule Counting technology that identifies minute quantities of biomarker molecules in the blood before clinical symptoms are apparent. This technology is up to 100 times more sensitive than traditional testing platforms, enabling unprecedented insight into medical conditions. ^1,2

¹ Apple F, et al. Clin Chem. 2009; 55: 1303-6
² Validation data on file at Singulex

Singulex technology provides what other tests cannot: The sensitivity to distinguish people who have disease from those who do not, before symptoms are apparent, leading to earlier identification of disease and improved monitoring of therapies.

• Cardiac Troponin I (SMC^TM* cTnI ): Measures small amounts of cardiac troponin I, a protein found specifically in heart muscles that is released into the bloodstream when heart muscle is injured or stressed.
• Endothelin (SMC^TM* Endothelin): Measures the tightening of blood vessels, which can raise blood pressure. A high level may predict how far along blood vessel disease has progressed and may be related to chronic heart failure, kidney disease, sleep apnea or diabetes.
• Interleukin-6 (SMC^TM* IL-6), Interleukin-17A (SMC^TM* IL-17A), and Tumor Necrosis Factor-alpha (SMC^TM* TNF-α): Measure inflammatory proteins in the blood stream. Inflammation may cause plaque build-up in the arteries. If left untreated, this build-up can increase the risk of having a heart attack or stroke.

*This test was developed and its performance characteristic determined by the Singulex Clinical Laboratory. It has not been cleared or approved by the U.S. Food and Drug Administration. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.

Ask your healthcare provider to determine if you would benefit from getting Singulex tests. Your healthcare provider will then give you a test requisition form to get blood tests at your doctor’s office or local blood draw lab. The blood samples are shipped to the Singulex Clinical Laboratory and the test results are sent to your healthcare provider.

You can get a copy of your test results from the health care provider who ordered your tests or click here.

Your healthcare provider will help you interpret your test results. After you have discussed your test results with your provider, you can give us a call and speak with one of our nurses to further discuss any other questions. You can also review the blood test descriptions to help you interpret results.

Multiple insurance companies, including Medicare and private health care companies, have established in-network coverage policies for the majority of Singulex testing. Please call Customer Service at 1-800-400-4344 or contact us via email if you have questions about your health care plan benefits.

• When you owe a copayment or deductible for Singulex tests
• When you are paying for Singulex tests directly
• When you have received a check from your insurance company and you have not yet forwarded the check to Singulex

A Singulex Customer Service Representative can help you understand the EOB statement that your insurance company created for you. Please call Customer Service at 1-800-400-4344.

Please call Customer Service at 1-800-400-4344 for a cost estimate.

Please call Customer Service at 1-800-400-4344 and we will work with you to help answer your questions.

Singulex is pleased to offer a Financial Assistance Program to help patients. Participation must be requested by you, the patient, and is subject to financial eligibility.